1008119-07-0 Usage
Uses
Used in Organic Synthesis:
2,6-Difluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzoic acid is used as a building block in organic synthesis for its ability to undergo various chemical reactions, facilitating the creation of new molecules with diverse applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2,6-Difluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzoic acid is utilized as a key intermediate for the development of pharmaceutical compounds. Its unique structure allows for the design of molecules with potential therapeutic properties, contributing to the advancement of new drug candidates.
Used in the Development of New Molecules with Biological or Pharmaceutical Applications:
The boron-containing group in 2,6-Difluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzoic acid can participate in a range of reactions, making it a valuable tool for the synthesis of new molecules with potential biological or pharmaceutical applications. This versatility positions the compound as a significant contributor to the discovery and development of innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1008119-07-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,8,1,1 and 9 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1008119-07:
(9*1)+(8*0)+(7*0)+(6*8)+(5*1)+(4*1)+(3*9)+(2*0)+(1*7)=100
100 % 10 = 0
So 1008119-07-0 is a valid CAS Registry Number.
1008119-07-0Relevant articles and documents
MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
-
Page/Page column 67, (2009/04/24)
Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity, including inflammatory and immune diseases, having the structure of formula (I): an en